Monday, October 26, 2026 · Daily editionET --:--:--

Regulator

Under 510(k) clearance K252675, the FDA cleared da Vinci SP for nipple-sparing mastectomy, a breast cancer operation.

A regulator's decision · Sets da Vinci SP's stage

What the source says

“The subsequent issuance of K252675 has exacerbated those concerns and warrants immediate agency action.”
Citizen petition to FDA, Feb 2026

What it means

da Vinci SP, from Intuitive, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. This event is one of the milestones that placed it there.

Human help: A surgeon in the operating room controls it; it doesn't operate on its own.